cilostamide has been researched along with Atrial Fibrillation in 1 studies
cilostamide: selective inhibitor of cyclic AMP phosphodiesterase & platelet aggregation; structure
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rozmaritsa, N | 1 |
| Christ, T | 1 |
| Van Wagoner, DR | 1 |
| Haase, H | 1 |
| Stasch, JP | 1 |
| Matschke, K | 1 |
| Ravens, U | 1 |
1 other study available for cilostamide and Atrial Fibrillation
| Article | Year |
|---|---|
Attenuated response of L-type calcium current to nitric oxide in atrial fibrillation.
Topics: Atrial Fibrillation; Calcium; Calcium Channels, L-Type; Cyclic AMP; Cyclic GMP; Humans; Myocardium; | 2014 |